miDiagnostics NV
Latest round
- Series D
Last raised
- Dec 2024
Total raised
- $17M
Investors
- 4
About miDiagnostics NV
Founded in 2015 and headquartered in Leuven, Belgium, miDiagnostics NV focuses on developing diagnostic testing solutions., and participated in by Alychlo, Pamica, and VMF Invest.miDiagnostics primarily specializes in advanced diagnostic testing solutions powered by proprietary silicon chip technology. The core product offering includes a highly precise and cost-effective test-card designed for rapid point-of-care testing. This innovative product facilitates ultrafast PCR (polymerase chain reaction) testing, enabling healthcare professionals to deliver diagnostic information efficiently to both clinicians and patients. The end use cases target critical healthcare settings, including nursing homes and home care environments, where timely intervention is essential for managing outbreaks.miDiagnostics generates revenue through the sale of its specialized diagnostic test-cards, which are employed in clinical and point-of-care testing scenarios. The company engages in direct sales to healthcare institutions and partners with bio-pharma firms, creating a business model that combines B2B transactions with direct-to-consumer engagements.70. The company aims to expand its product offerings and strategically target new markets for its diagnostic solutions, enhancing its presence in the biopharma sector.
Who invested in miDiagnostics NV
4 investors across 1 round
See all investors in miDiagnostics NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Dec 27, 2024
Amount
$17M
Investors
Questions about miDiagnostics NV
Who invested in miDiagnostics NV?
miDiagnostics NV has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has miDiagnostics NV raised?
miDiagnostics NV has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did miDiagnostics NV last raise money?
miDiagnostics NV's most recent round on record is a Series D, in Dec 2024.
What does miDiagnostics NV do?
Founded in 2015 and headquartered in Leuven, Belgium, miDiagnostics NV focuses on developing diagnostic testing solutions.
Where is miDiagnostics NV headquartered?
miDiagnostics NV is headquartered in Leuven, Belgium.
Which VCs invest in companies like miDiagnostics NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at miDiagnostics NV's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like miDiagnostics NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.